2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide

C17H20N4O3 — CID 36802685

IUPAC2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide
SMILESCc1cc(NC(=O)CN(Cc2ccco2)Cc2ccco2)n(C)n1
InChIInChI=1S/C17H20N4O3/c1-13-9-16(20(2)19-13)18-17(22)12-21(10-14-5-3-7-23-14)11-15-6-4-8-24-15/h3-9H,10-12H2,1-2H3,(H,18,22)
InChIKeyKFMCRQQQVOAVJY-UHFFFAOYSA-N
MW328.37 g/mol
LogP2.56
Rot. Bonds7

About 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide

2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide (PubChem CID 36802685) has the molecular formula C17H20N4O3 and a molecular weight of 328.37 g/mol. Its IUPAC name is 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide.

Molecular Properties

Compound Name2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide
PubChem CID36802685
Molecular FormulaC17H20N4O3
Molecular Weight328.37 g/mol
Exact Mass328.15
IUPAC Name2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide
SMILESCc1cc(NC(=O)CN(Cc2ccco2)Cc2ccco2)n(C)n1
InChIInChI=1S/C17H20N4O3/c1-13-9-16(20(2)19-13)18-17(22)12-21(10-14-5-3-7-23-14)11-15-6-4-8-24-15/h3-9H,10-12H2,1-2H3,(H,18,22)
InChIKeyKFMCRQQQVOAVJY-UHFFFAOYSA-N
XLogP2.56
TPSA76.44 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500328.37
LogP ≤ 52.56
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[bis(furan-2-ylmethyl)amino]-N-[2,6-di(propan-2-yl)phenyl]acetamide
CID 46614486
2-[bis(furan-2-ylmethyl)amino]-N-methylacetamide
CID 27118866
2-[bis(furan-2-ylmethyl)amino]-N-(2,6-difluorophenyl)acetamide
CID 8840881
N-(3-acetylphenyl)-2-[bis(furan-2-ylmethyl)amino]acetamide
CID 8840674
2-[bis(furan-2-ylmethyl)amino]-N-(3-propan-2-yl-1,2-oxazol-5-yl)acetamide
CID 24626993
2-[bis(furan-2-ylmethyl)amino]-N-[3-(4-methylphenyl)-1,2-oxazol-5-yl]acetamide
CID 8841949
2-[bis(furan-2-ylmethyl)amino]-N-(3-methylsulfanylphenyl)acetamide
CID 27119061
2-[cycloheptyl(methyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide
CID 36803387
2-[ethyl(furan-2-ylmethyl)amino]-N-(1,3,4-thiadiazol-2-yl)acetamide
CID 47284425
2-[bis(furan-2-ylmethyl)amino]-N-[4-[ethyl(propan-2-yl)amino]phenyl]acetamide
CID 27118860
2-[[4-amino-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-(2,5-dimethylpyrazol-3-yl)acetamide
CID 134046005
N-(2,6-dimethylphenyl)-2-[furan-2-ylmethyl(thiophen-2-ylmethyl)amino]acetamide
CID 8677649

Frequently Asked Questions

What is the IUPAC name of 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide?
The IUPAC name of 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide (CID 36802685) is 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide.
What is the SMILES notation for 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide?
The canonical SMILES for 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide is Cc1cc(NC(=O)CN(Cc2ccco2)Cc2ccco2)n(C)n1.
What is the InChIKey of 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide?
The InChIKey is KFMCRQQQVOAVJY-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H20N4O3/c1-13-9-16(20(2)19-13)18-17(22)12-21(10-14-5-3-7-23-14)11-15-6-4-8-24-15/h3-9H,10-12H2,1-2H3,(H,18,22).
What are the key properties of 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide?
2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide has a molecular weight of 328.37 g/mol, XLogP of 2.56, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[bis(furan-2-ylmethyl)amino]-N-(2,5-dimethylpyrazol-3-yl)acetamide is sourced from PubChem (CID 36802685), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).